Insulin Dose Adjustment After 1 Hour of Inadequate Response
If random blood sugar (RBS) remains elevated 1 hour after an appropriate insulin dose, do not give additional rapid-acting insulin immediately—wait at least 3 hours to avoid "insulin stacking" and severe hypoglycemia. 1
Understanding Insulin Action and Timing
- Rapid-acting insulin analogs (lispro, aspart, glulisine) have an onset of 0.25–0.5 hours, peak at 1–3 hours, and duration of 3–5 hours; at 1 hour post-injection, the insulin is still actively lowering glucose and has not yet reached peak effect. 2
- Regular (short-acting) insulin has an even longer action profile with peak at 2–4 hours and duration of 6–8 hours, meaning 1 hour is far too early to assess full effect. 1
- Administering additional insulin before the first dose has completed its action creates "insulin stacking," where overlapping insulin doses cause cumulative hypoglycemia risk that is difficult to predict or manage. 1
Evidence-Based Correction Insulin Protocol
When to Give Correction Doses
- Correction insulin should only be given at scheduled times (before meals or every 4–6 hours for hospitalized patients), not based on a single 1-hour glucose reading. 1
- For hospitalized patients eating regular meals, check glucose before each meal and at bedtime (minimum 4 times daily) to guide correction doses. 1
- For patients with poor oral intake or NPO, check glucose every 4–6 hours and give correction doses only at these intervals. 1
Simplified Correction Scale
- Add 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL (13.9 mmol/L). 1
- Add 4 units of rapid-acting insulin for pre-meal glucose >350 mg/dL (19.4 mmol/L). 1
- These correction doses are given in addition to scheduled basal and prandial insulin, never as monotherapy. 1
Individualized Correction Using Insulin Sensitivity Factor (ISF)
- Calculate ISF = 1500 ÷ total daily insulin dose for regular insulin, or ISF = 1700 ÷ total daily insulin dose for rapid-acting analogs. 1
- Correction dose = (Current glucose – Target glucose) ÷ ISF. 1
- Example: If total daily dose is 50 units, ISF = 1500 ÷ 50 = 30 mg/dL per unit; for glucose of 280 mg/dL with target 120 mg/dL, correction = (280 – 120) ÷ 30 = 5.3 units, rounded to 5 units. 1
What to Do at 1 Hour Post-Insulin
Immediate Actions
- Do not administer additional insulin at 1 hour unless glucose is >300 mg/dL with symptoms (nausea, vomiting, altered mental status) suggesting diabetic ketoacidosis. 1
- If glucose >300 mg/dL with symptoms, check urine or blood ketones immediately; if ketones are present, this is a medical emergency requiring IV insulin infusion, not subcutaneous correction doses. 1
- For asymptomatic hyperglycemia at 1 hour, simply wait and recheck glucose at the next scheduled time (before next meal or in 3–4 hours). 1
Monitoring Protocol
- Recheck glucose 2 hours after the meal (not 1 hour) to assess adequacy of the prandial insulin dose; target post-prandial glucose <180 mg/dL (10.0 mmol/L). 1
- If 2-hour post-prandial glucose consistently exceeds 180 mg/dL, increase the prandial insulin dose for that meal by 1–2 units (≈10–15%) every 3 days, not by giving extra correction doses. 1
- Daily fasting glucose should be measured to guide basal insulin adjustments; if fasting glucose is ≥180 mg/dL, increase basal insulin by 4 units every 3 days. 1
Adjusting the Scheduled Insulin Regimen (Not Correction Doses)
When Basal Insulin Is Inadequate
- If fasting glucose remains ≥180 mg/dL despite correction doses, the basal insulin dose is too low and must be increased by 4 units every 3 days until fasting glucose reaches 80–130 mg/dL. 1
- If fasting glucose is 140–179 mg/dL, increase basal insulin by 2 units every 3 days. 1
- Stop basal escalation when the dose approaches 0.5–1.0 units/kg/day without achieving targets; at this threshold, add prandial insulin rather than further increasing basal insulin to avoid "over-basalization." 1
When Prandial Insulin Is Inadequate
- If pre-meal glucose is controlled but post-prandial glucose consistently exceeds 180 mg/dL, the prandial insulin dose is too low. 1
- Increase the prandial insulin dose for the problematic meal by 1–2 units every 3 days based on 2-hour post-prandial glucose readings. 1
- Never give rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 1
Critical Pitfalls to Avoid
- Do not rely solely on correction (sliding-scale) insulin without adjusting scheduled basal and prandial doses; major diabetes guidelines condemn this reactive approach as ineffective and dangerous. 1
- Do not give correction insulin more frequently than every 3–4 hours for rapid-acting insulin or every 6 hours for regular insulin, to avoid insulin stacking. 1
- Do not assume a single elevated glucose reading at 1 hour indicates treatment failure; insulin is still actively working and has not yet reached peak effect. 2
- Do not continue escalating basal insulin beyond 0.5–1.0 units/kg/day without addressing post-prandial hyperglycemia with prandial insulin; this leads to over-basalization with increased hypoglycemia risk. 1
When to Seek Immediate Medical Attention
- Glucose >300 mg/dL (16.7 mmol/L) with symptoms (nausea, vomiting, abdominal pain, altered mental status) warrants immediate evaluation for diabetic ketoacidosis. 1
- Presence of ketones (urine ≥trace or blood ≥0.5 mmol/L) requires urgent medical care and IV insulin infusion, not subcutaneous correction doses. 1
- Persistent glucose >300 mg/dL despite two correction doses given at appropriate intervals (≥3–4 hours apart) indicates fundamental under-dosing and requires regimen restructuring. 1
Expected Outcomes with Proper Insulin Management
- With a properly implemented basal-bolus regimen (scheduled basal + prandial + correction doses at appropriate intervals), ≈68% of patients achieve mean glucose <140 mg/dL, compared with ≈38% using inadequate sliding-scale approaches. 1
- Properly timed correction doses do not increase hypoglycemia risk when given at scheduled intervals (every 3–4 hours minimum) rather than reactively at 1 hour. 1
- HbA1c reductions of 2–3% (or 3–4% in severe hyperglycemia) are achievable over 3–6 months with intensive insulin titration using scheduled doses, not frequent corrections. 1